Thoracoscopic patients in thoracic surgery
Conditions
Interventions
Oxycodone group:5 minutes before the end of the operation, 5 mg of oxycodone injection was given
Sufentanil group:5 minutes before the end of the operation, Sufentanil injection 5ug
Sponsors
Taizhou First People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Age between 18-65 years old, regardless of gender (2) American Society of Anesthesiologists (ASA) Grade I-II (3) Planned thoracoscopic lung surgery; (4) Participate in this study voluntarily and sign the informed consent form
Exclusion criteria
Exclusion criteria: (1) Body mass index (BMI) >= 30 kg/m^2; (2) Pregnancy or breastfeeding; (3) A history of mental illness or severe brain damage that prevents them from communicating correctly; (4) Long-term use of opioids or use of monoamine oxidase inhibitors (MAOI) antidepressants; (5) A history of allergy to oxycodone or sufentanil; (6) Contraindications to oxycodone hydrochloride (such as respiratory depression or paralytic intestinal obstruction, etc.); (7) PCIA is not suitable due to circulatory instability or hypovolemic state; (8) Incomplete clinical data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS Scores of Resting Pain and Cough Pain; | — |
Secondary
| Measure | Time frame |
|---|---|
| Ramsay sedation score was performed ;Cumulative number of analgesic pump presses and ineffective presses;QoR-15 scales were scored ;Satisfaction;Postoperative hypoxemia, respiratory depression, constipation and other adverse reactions; | — |
Countries
China
Contacts
Public ContactWang Wenwei
Taizhou First People's Hospital
Outcome results
None listed